GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation ...
A study by Cleveland Clinic and USC researchers long-term risk associated with COVID-19 “continues to pose a significant ...
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can ...
Research suggests a surprising link between digestive health and heart health. Digestion problems, especially chronic ones ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
A heart attack and stroke are both serious health conditions that occur when there's a blockage in the arteries (blood vessels). This blockage causes a reduction in proper blood flow to the heart ...
A new study says that type 2 diabetes medications GLP-1 agonists and SGLT2 inhibitors may help lower a stroke survivor’s risk of experiencing a subsequent stroke, heart attack, or death ...
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death ...
Sleep deprivation has become a common problem several people face on a daily basis. But, it may put you at risk of heart ...
Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback